Financhill
Back

Innovator IBD Breakout Opportunities ETF Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
33

BOUT
Innovator IBD Breakout Opportunities ETF

Last Price:
$36.32
Seasonality Move:
-0.07%
Sell
45

DRUG
Bright Minds Biosciences

Last Price:
$35.96
Seasonality Move:
-28.52%
Sell
33
Innovator IBD Breakout Opportunities ETF (BOUT) is a Sell

Is Innovator IBD Breakout Opportunities ETF a Buy, Sell or Hold?

  • The current Innovator IBD Breakout Opportunities ETF [BOUT] share price is $36.66. The Score for BOUT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BOUT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $34.34. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BOUT Stock Price Chart

What is Innovator IBD Breakout Opportunities ETF's stock price today?

  • The Innovator IBD Breakout Opportunities ETF share price today is $36.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOUT is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $34.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

BOUT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 31.45 Sell
Chaikin Money Flow: 2122 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.97 - 40.73) Sell
Bollinger Bands (100): (37.92 - 41.06) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.96 Sell
Relative Strength Index (14 RSI): 45.83 Sell
Chaikin Money Flow: 19166 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.91 - 42.27) Sell
Bollinger Bands (100): (32.26 - 45.88) Sell

BOUT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.67 Sell
20-day SMA: 39.03 Sell
50-day SMA: 39.71 Sell
200-day SMA: 37.5 Sell
8-day EMA: 37.7 Sell
20-day EMA: 38.62 Sell
50-day EMA: 39.33 Sell
200-day EMA: 37.79 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.86 Sell
20-day SMA: 37.71 Sell
50-day SMA: 37.1 Sell
200-day SMA: 20.1 Buy
8-day EMA: 35.01 Sell
20-day EMA: 36.11 Sell
50-day EMA: 36.53 Sell
200-day EMA: 24.85 Buy

Innovator IBD Breakout Opportunities ETF Earnings Growth & BOUT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.84 per share, and a decrease next year of $1.29 per share.

Innovator IBD Breakout Opportunities ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):